Navigation Links
MacroChem Appoints David P. Luci as New CFO
Date:3/19/2008

WELLESLEY HILLS, Mass., March 19 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) today announced the appointment of David P. Luci to the position of Chief Financial Officer, effective immediately. Mr. Luci has served as MacroChem's General Counsel and Vice President, Corporate Development since joining the Company in December 2007.

Mr. Luci was formerly the CFO of Bioenvision, Inc. prior to its successful merger transaction with Genzyme Corporation valued at $345 mm, and has over 16 years of experience servicing or working in the finance, accounting and legal functions within the healthcare industry. Bioenvision's primary focus was developing compounds for the treatment of cancer. While Mr. Luci was at Bioenvision, the company raised over $100 million of capital through equity financings, primarily lead by UBS and JP Morgan, and developed and successfully obtained regulatory approval for a compound to treat pediatric acute leukemia in end-stage patients.

Mr. Luci is also a member of the board of directors, audit committee chairman and compensation committee chairman of Access Pharmaceuticals (OTC Bulletin Board: ACCP.OB) of Dallas, Texas, a biopharmaceutical company focused on development of novel therapies for cancer and other indications. Prior to Bioenvision he also served as a senior associate in the corporate department of Paul, Hastings, Janofsky & Walker LLP (New York Office) and senior auditor at Ernst & Young, LLP (New York Office). In 1991, Mr. Luci earned certification in public accounting.

Mr. Luci stated. "Since joining the company, I have been further encouraged by our potential for future success and look forward to working in this expanded role through the coming stages of growth and opportunity for the Company."

Bernard Patriacca, MacroChem's Chief Financial Officer, will be retiring as planned following the filing of the company's annual report for the year ended December 31, 2007 which
'/>"/>

SOURCE MacroChem Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York
2. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
3. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
4. Kosans Board of Directors Appoints Helen S. Kim as Chief Executive Officer
5. RainDance Appoints Becker Chief Commercial Officer
6. Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors
7. iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
8. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
9. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
10. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
11. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Research ... "Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014" ... Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 ... state of the global isotope ratio mass spectrometer industry. ... the industry including definitions, classifications, applications and industry chain ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
(Date:8/26/2014)... they believe is the thinnest-possible semiconductor, a new ... three atoms thick. , The University of Washington ... semiconductor materials can be connected in an atomically ... could be the basis for next-generation flexible and ... solar technologies. , "Heterojunctions are fundamental elements of ...
(Date:8/26/2014)... 2014 - A team of engineers from Singapore ... sensor network (WSN) for satellite communications. , With ... in satellite design, constructing a lightweight, low power-consuming, ... inside the satellite has always been a challenge ... the Satellite Research Centre of Nanyang Technological University ...
Breaking Biology Technology:Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2ZigBee in the Sky 2
... 3 Sangamo BioSciences,Inc. (Nasdaq: SGMO ) announced ... will provide an update on the progress of,Sangamo,s ZFP ... strategy at 12:45pm (PT) on Wednesday, October 10, 2007,at ... will be webcast live and may be accessed via ...
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceutical ... candidates principally,for use in the hospital setting, announced ... will present the corporate overview on,Wednesday, October 10, ... Eastern Time),during the BIO Investor Forum in San ...
... Laboratories to 45%, GURGAON, India, Oct. 3 ... announced the,signing of Definitive Agreements, providing for an increase ... 45% at a price of Rs. 160 per share,aggregating ... of shares from the existing Promoters (b) Preferential ...
Cached Biology Technology:Sangamo BioSciences to Present at the 2007 BIO InvestorForum 2Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIO Investor Forum 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 3
(Date:8/27/2014)... Outstanding basic research, a growing focus on translating ... care have earned the Herbert Irving Comprehensive Cancer ... and NewYork-Presbyterian Hospital an $18 million, five-year Cancer ... (NCI). The grant renews the center,s status as ... in New York City and one of only ...
(Date:8/27/2014)... of studies have shown that excessive iron ... Parkinson,s disease. Previous studies from Chunyan Guo ... China have shown that baicalin prevented iron ... metal transporter 1 expression, and increased ferroportin ... rotenone-induced Parkinson,s disease rats. However, the relationship ...
(Date:8/27/2014)... ago the Happy Camp Complex of fires had consumed ... complex had consumed 35,530 as of eight hours ago. ... Happy Camp Ranger District of the Klamath National Forest ... 11, 2014. All but three of those fires are ... of contained fires and their size at containment: Delta, ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Happy Camp and July Fire Complexes in California 2
... The TWAS 22nd General Meeting will take place on ... Theoretical Physics (ICTP), home to the Academy,s secretariat. TWAS,s ... by Romain Murenzi, executive director of TWAS; Fernando Quevedo, ... Affairs, Italy; and Jacob Palis, TWAS President, will highlight ...
... American Heart Association will today present Gladstone Institutes ... PhD, with the 2011 AHA Distinguished Scientist Award, ... founding cardiovascular scientists. The Distinguished Scientist Award ... Association can give a scientist. Dr. Mahley is ...
... 2 million people each year, is caused primarily by infectious ... Mtb . Mtb targets human immune cells as ... body,s immune response. Up until now, scientists ... the Immunity and Infection Research Centre at Vancouver Coastal Health ...
Cached Biology News:TWAS 22nd General Meeting in Trieste 2Gladstone founder receives American Heart Association Distinguished Scientist Award 2Researchers uncover why the body can't defend against tuberculosis 2